Blue Jean Financial LLC Acquires New Position in GE HealthCare Technologies Inc. $GEHC

Blue Jean Financial LLC acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 20,244 shares of the company’s stock, valued at approximately $1,660,000.

A number of other large investors also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after purchasing an additional 267,058 shares during the period. Dodge & Cox increased its stake in GE HealthCare Technologies by 13.4% in the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock worth $2,559,945,000 after purchasing an additional 3,693,918 shares during the period. Capital Research Global Investors increased its stake in GE HealthCare Technologies by 1.6% in the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after purchasing an additional 389,796 shares during the period. State Street Corp increased its stake in GE HealthCare Technologies by 2.0% in the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after purchasing an additional 401,932 shares during the period. Finally, Geode Capital Management LLC increased its stake in GE HealthCare Technologies by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 12,112,503 shares of the company’s stock worth $989,673,000 after purchasing an additional 37,159 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $65.18 on Friday. The firm has a market cap of $29.65 billion, a P/E ratio of 15.59, a P/E/G ratio of 1.47 and a beta of 0.74. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The business’s 50 day moving average price is $66.32 and its 200-day moving average price is $75.20. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CFO James Saccaro acquired 3,310 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were purchased at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the transaction, the chief financial officer owned 87,471 shares in the company, valued at $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kevin Lobo acquired 10,000 shares of the business’s stock in a transaction dated Friday, May 22nd. The stock was acquired at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director owned 14,363 shares in the company, valued at approximately $921,817.34. The trade was a 229.20% increase in their position. The SEC filing for this purchase provides additional information. In the last quarter, insiders purchased 21,847 shares of company stock worth $1,361,355. Corporate insiders own 0.36% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have commented on GEHC. Oppenheimer reaffirmed an “outperform” rating and issued a $85.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Stifel Nicolaus set a $80.00 price target on GE HealthCare Technologies in a research note on Wednesday, April 29th. HSBC decreased their price target on GE HealthCare Technologies from $100.00 to $90.00 in a research note on Thursday, April 30th. Evercore set a $80.00 price target on GE HealthCare Technologies in a research note on Thursday, April 30th. Finally, Argus decreased their price target on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Tuesday, May 19th. Nine analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.21.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.